行情

ATHE

ATHE

Alterity Therapeutics Ltd
NASDAQ

实时行情|Nasdaq Last Sale

1.045
-0.035
-3.22%
已收盘, 16:00 11/12 EST
开盘
1.010
昨收
1.080
最高
1.080
最低
1.010
成交量
3,774
成交额
--
52周最高
2.720
52周最低
0.9100
市值
15.50万
市盈率(TTM)
-1.2502
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ATHE 新闻

  • 美股盘前:严阵以待鲍威尔证词 期指集体走弱
  • 新浪美股.32分钟前
  • 阿里启动香港IPO 软银实益拥有25.8%已发行在外股份
  • 新浪科技.46分钟前
  • 猎豹移动2019年Q3净利润4.9亿 同比增长152%
  • 新浪科技.1小时前
  • 英国通胀率降至近三年低点 因公用事业费率上限影响
  • 新浪财经综合.1小时前

更多

所属板块

生物技术和医学研究
+0.28%
制药与医学研究
+0.27%

热门股票

名称
价格
涨跌幅

ATHE 简况

Alterity Therapeutics Limited, formerly Prana Biotechnology Limited, is a development-stage medical biotechnology company. The Company is engaged in the research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's disease, Huntington disease, Parkinson's disease and other neurological disorders. The Company's lead product candidates are PBT2 and PBT434. The Company's lead drug candidate PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. The Company also has advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing. Its other applications for its therapies include certain cancers, age-related macular degeneration, Motor Neuron disease, Creutzfeldt-Jakob disease (the human variant of Mad Cow disease), and a range of orphan neurodegenerative disorders.
展开

Webull提供Alterity Therapeutics Ltd (ADR)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。